at Nasdaq.com (Tue, 2:51PM)
Sublingual immunotherapy, a liquid treatment for allergies taken under the tongue, is becoming...
Sublingual immunotherapy, a liquid treatment for allergies taken under the tongue, is becoming increasingly popular as an alternative to traditional allergy shots. While not yet approved by the FDA, the treatment could be a boon for the company that gets there first, and there are at least three companies, including heavyweight Merck (MRK +1%), that are funding large U.S. studies aimed at getting it approved in the next few years.
From other sites
at Nasdaq.com (Mon, 12:38PM)
at Zacks.com (Jan 16, 2015)
at Zacks.com (Jan 15, 2015)
at Nasdaq.com (Jan 15, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs